Half-year report · HY
2927.TEDINET S100XXJB
Period2025-09-01 → 2026-02-28
Filed2026-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.8bn | 2025-09-01 → 2026-02-28 | Cons. | Net sales |
| Revenue | ¥32.7bn | 2024-09-01 → 2025-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.6bn | 2024-09-01 → 2025-02-28 | Cons. | Net sales |
| Operating income | ¥1.3bn | 2025-09-01 → 2026-02-28 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2024-09-01 → 2025-02-28 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2025-09-01 → 2026-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2024-09-01 → 2025-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2024-09-01 → 2025-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥1.2bn | 2025-09-01 → 2026-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥1.4bn | 2024-09-01 → 2025-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥801m | 2025-09-01 → 2026-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-09-01 → 2025-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥881m | 2024-09-01 → 2025-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥804m | 2025-09-01 → 2026-02-28 | Cons. | Profit loss |
| Net income | ¥926m | 2024-09-01 → 2025-02-28 | Cons. | Profit loss |
| Total assets | ¥50.3bn | at 2026-02-28 | Cons. | Assets |
| Total assets | ¥48.7bn | at 2025-08-31 | Cons. | Assets |
| Total assets | ¥47.7bn | at 2025-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥34.0bn | at 2026-02-28 | Cons. | Liabilities |
| Total liabilities | ¥33.5bn | at 2025-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥16.2bn | at 2026-02-28 | Cons. | Net assets |
| Net assets / equity | ¥15.2bn | at 2025-08-31 | Cons. | Net assets |
| Net assets / equity | ¥14.8bn | at 2025-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.1bn | at 2026-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.3bn | at 2025-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.8bn | at 2026-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.2bn | at 2025-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.2bn | at 2025-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2024-08-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.8bn | 2025-09-01 → 2026-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2024-09-01 → 2025-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥566m | 2024-09-01 → 2025-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.2bn | 2025-09-01 → 2026-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.3bn | 2024-09-01 → 2025-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.9bn | 2024-09-01 → 2025-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥48m | 2025-09-01 → 2026-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥667m | 2024-09-01 → 2025-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥594m | 2024-09-01 → 2025-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥55.76 | 2025-09-01 → 2026-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.98 | 2024-09-01 → 2025-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.65 | 2024-09-01 → 2025-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥102.97 | 2024-09-01 → 2025-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥62.64 | 2024-09-01 → 2025-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.9% | at 2026-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.9% | at 2025-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.7% | at 2025-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-09-01 → 2026-02-28 | ¥1.0bn |
| Otherother segments | revenue external | 2025-09-01 → 2026-02-28 | ¥1.0bn |
| Otherother segments | revenue intersegment | 2025-09-01 → 2026-02-28 | ¥11m |
| Otherother segments | segment profit | 2025-09-01 → 2026-02-28 | −¥80m |
| Reconciling Itemsreconciling | revenue | 2025-09-01 → 2026-02-28 | −¥156m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-09-01 → 2026-02-28 | −¥156m |
| Reconciling Itemsreconciling | segment profit | 2025-09-01 → 2026-02-28 | −¥16m |
| Department Store Businessreportable segment | revenue | 2025-09-01 → 2026-02-28 | ¥2.4bn |
| Department Store Businessreportable segment | revenue external | 2025-09-01 → 2026-02-28 | ¥2.4bn |
| Department Store Businessreportable segment | revenue intersegment | 2025-09-01 → 2026-02-28 | ¥7m |
| Department Store Businessreportable segment | segment profit | 2025-09-01 → 2026-02-28 | ¥31m |
| Food Service Businessreportable segment | revenue | 2025-09-01 → 2026-02-28 | ¥1.3bn |
| Food Service Businessreportable segment | revenue external | 2025-09-01 → 2026-02-28 | ¥1.2bn |
| Food Service Businessreportable segment | revenue intersegment | 2025-09-01 → 2026-02-28 | ¥25m |
| Food Service Businessreportable segment | segment profit | 2025-09-01 → 2026-02-28 | −¥19m |
| Health Carereportable segment | revenue | 2025-09-01 → 2026-02-28 | ¥9.9bn |
| Health Carereportable segment | revenue external | 2025-09-01 → 2026-02-28 | ¥9.8bn |
| Health Carereportable segment | revenue intersegment | 2025-09-01 → 2026-02-28 | ¥92m |
| Health Carereportable segment | segment profit | 2025-09-01 → 2026-02-28 | ¥1.2bn |
| Medical Productsreportable segment | revenue | 2025-09-01 → 2026-02-28 | ¥1.3bn |
| Medical Productsreportable segment | revenue external | 2025-09-01 → 2026-02-28 | ¥1.3bn |
| Medical Productsreportable segment | revenue intersegment | 2025-09-01 → 2026-02-28 | ¥7m |
| Medical Productsreportable segment | segment profit | 2025-09-01 → 2026-02-28 | ¥158m |
| Real Estate And Consignment Businessreportable segment | revenue | 2025-09-01 → 2026-02-28 | ¥1.1bn |
| Real Estate And Consignment Businessreportable segment | revenue external | 2025-09-01 → 2026-02-28 | ¥1.1bn |
| Real Estate And Consignment Businessreportable segment | revenue intersegment | 2025-09-01 → 2026-02-28 | ¥15m |
| Real Estate And Consignment Businessreportable segment | segment profit | 2025-09-01 → 2026-02-28 | ¥14m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-09-01 → 2026-02-28 | ¥17.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-09-01 → 2026-02-28 | ¥16.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-09-01 → 2026-02-28 | ¥156m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-09-01 → 2026-02-28 | ¥1.3bn |
| Otherother segments | revenue | 2024-09-01 → 2025-02-28 | ¥961m |
| Otherother segments | revenue external | 2024-09-01 → 2025-02-28 | ¥946m |
| Otherother segments | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥15m |
| Otherother segments | segment profit | 2024-09-01 → 2025-02-28 | −¥75m |
| Reconciling Itemsreconciling | revenue | 2024-09-01 → 2025-02-28 | −¥120m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-09-01 → 2025-02-28 | −¥120m |
| Reconciling Itemsreconciling | segment profit | 2024-09-01 → 2025-02-28 | −¥50m |
| Department Store Businessreportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥2.4bn |
| Department Store Businessreportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥2.4bn |
| Department Store Businessreportable segment | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥4m |
| Department Store Businessreportable segment | segment profit | 2024-09-01 → 2025-02-28 | ¥35m |
| Food Service Businessreportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥1.2bn |
| Food Service Businessreportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥1.1bn |
| Food Service Businessreportable segment | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥21m |
| Food Service Businessreportable segment | segment profit | 2024-09-01 → 2025-02-28 | −¥39m |
| Health Carereportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥9.6bn |
| Health Carereportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥9.6bn |
| Health Carereportable segment | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥63m |
| Health Carereportable segment | segment profit | 2024-09-01 → 2025-02-28 | ¥1.4bn |
| Medical Productsreportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥1.3bn |
| Medical Productsreportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥1.2bn |
| Medical Productsreportable segment | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥6m |
| Medical Productsreportable segment | segment profit | 2024-09-01 → 2025-02-28 | ¥91m |
| Real Estate And Consignment Businessreportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥1.4bn |
| Real Estate And Consignment Businessreportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥1.4bn |
| Real Estate And Consignment Businessreportable segment | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥11m |
| Real Estate And Consignment Businessreportable segment | segment profit | 2024-09-01 → 2025-02-28 | −¥49m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-09-01 → 2025-02-28 | ¥16.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-09-01 → 2025-02-28 | ¥16.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥120m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-09-01 → 2025-02-28 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 611
| Item | Context | Value | Unit |
|---|---|---|---|
| Place of filing cover page | FilingDateInstant | Original text (Japanese)東海財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-04-14 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第46期中(自 2025年９月１日 至 2026年２月28日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ＡＦＣ－ＨＤアムスライフサイエンス | |
| Company name in english cover page | FilingDateInstant | ＡＦＣ－ＨＤ ＡＭＳ Life Science Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役会長 淺 山 雄 彦 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)静岡県静岡市駿河区豊田三丁目６番36号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)054-281-0585(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役会長室長 南 方 茂 穂 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)静岡県静岡市駿河区豊田三丁目６番36号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)054-281-5238(直通) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役会長室長 南 方 茂 穂 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E01064 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 29270 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社ＡＦＣ－ＨＤアムスライフサイエンス | |
| Filer name in english | FilingDateInstant | AFC-HD AMS Life Science Co.,Ltd | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2025-09-01 | |
| Current period end date | FilingDateInstant | 2026-02-28 | |
| Type of current period | FilingDateInstant | HY | |
| Current fiscal year end date | FilingDateInstant | 2026-08-31 | |
| Previous fiscal year start date | FilingDateInstant | 2024-09-01 | |
| Comparative period end date | FilingDateInstant | 2025-02-28 | |
| Previous fiscal year end date | FilingDateInstant | 2025-08-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |